The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-8 of 8 articles
Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
Sardella G,
Beerkens F,
Dangas G,
Cao D,
Baber U,
Sartori S,
Cohen D,
Briguori C,
Gil R,
Nicolas J,
Zhang Z,
Dudek D,
Kunadian V,
Kornowski R,
Weisz G,
Claessen B,
Marx S,
Escaned J,
Huber K,
Collier T,
Moliterno D,
Ohman EM,
Krucoff M,
Kastrati A,
Steg G,
Angiolillo D,
Mehta SR,
Shlofmitz RA,
Sharma S,
Pocock S,
Gibson C,
Mehran R
December 2, 2022 | 10.4244/EIJ-D-22-00319
Antithrombotic strategy variability in atrial fibrillation and obstructive coronary disease revascularised with percutaneous coronary intervention: primary results from the AVIATOR 2 international registry
Chandrasekhar J,
Baber U,
Sartori S,
Goel R,
Nicolas J,
Vogel B,
Snyder C,
Kini A,
Briguori C,
Witzenbichler B,
Iakovou I,
Sardella G,
Marzo K,
DeFranco A,
Stuckey T,
Chieffo A,
Colombo A,
Shlofmitz RA,
Capodanno D,
Dangas G,
Pocock S,
Mehran R
October 7, 2022 | 10.4244/EIJ-D-21-01044
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
Dangas G,
Baber U,
Sharma S,
Giustino G,
Sartori S,
Nicolas J,
Goel R,
Mehta SR,
Cohen D,
Angiolillo D,
Zhang Z,
Camaj A,
Cao D,
Briguori C,
Dudek D,
Escaned J,
Huber K,
Collier T,
Kornowski R,
Kunadian V,
Moliterno D,
Ohman EM,
Weisz G,
Gil R,
Krucoff M,
Kaul U,
Oldroyd K,
Sardella G,
Shlofmitz RA,
Witzenbichler B,
Kastrati A,
Han Y,
Steg G,
Pocock S,
Gibson CM,
Mehran R
March 18, 2022 | 10.4244/EIJ-D-21-00721
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition
Gragnano F,
Spirito A,
Corpataux N,
Vaisnora L,
Galea R,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Billinger M,
Hunziker L,
Stortecky S,
Pilgrim T,
Bär S,
Ueki Y,
Capodanno D,
Urban P,
Pocock S,
Mehran R,
Heg D,
Windecker S,
Räber L,
Valgimigli M
December 3, 2021 | 10.4244/EIJ-D-21-00181
Prioritised endpoints for device-based hypertension trials: the win ratio methodology
April 2, 2021 | 10.4244/EIJ-D-20-01090
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
Jensen C,
Naber CK,
Urban P,
Ong P,
Valdés Chávarri M,
Abizaid A,
Pocock S,
Fabbiocchi F,
Dubois C,
Copt S,
Stoll H,
Morice M
March 20, 2018 | 10.4244/EIJ-D-17-00720
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial
Kappetein A,
Serruys P,
Sabik J,
Leon MB,
Taggart D,
Morice M,
Gersh B,
Pocock S,
Cohen D,
Wallentin L,
Ben-Yehuda O,
Van Es G-A,
Simonton C,
Stone G
September 18, 2016 | 10.4244/EIJV12I7A141
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023